company

FROGNER MED AS

2016 FROGNER

Return on Equity
13,59 %
Current Ratio
1,31
Debt-to-Equity Ratio
−65,42
Key figures (NOK)2022
Revenue564 000
Net Income−14 000
Total Assets6 686 000
Total Equity−103 000
Income (NOK)2022
Revenue564 000
Expenditure382 000
Operating Profit182 000
Financial Income0
Financial Costs196 000
Financial Balance−196 000
Earnings Before Tax−14 000
Tax0
Net Income−14 000
Balance (NOK)2022
Total Fixed Assets6 618 000
Total Current Assets67 000
Total Assets6 686 000
Total Retained Equity−133 000
Total Equity−103 000
Total Long-Term Debt6 738 000
Total Current Debt51 000
Total Equity and Debt6 686 000
Cash flow (NOK)2022
Sales Income0
Other Income564 000
Revenue564 000
Cost of Goods Sold0
Salary Costs0
Depreciation135 000
Impairment0
Expenditure382 000
Operating Profit182 000
Financial Income0
Financial Costs196 000
Financial Balance−196 000
Dividends0
Net Income−14 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate6 618 000
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets6 618 000
Total Fiancial Fixed Assets0
Total Fixed Assets6 618 000
Stock0
Total Investments0
Cash, Bank67 000
Total Current Assets67 000
Total Assets6 686 000
Total Equity−103 000
Short-Term Group Debt0
Total Long-Term Debt6 738 000
Creditors100 000
Unpaid Taxes0
Dividends0
Other Current Debt−49 000
Total Current Debt51 000
Total Equity and Debt6 686 000
Financial indicators2022
Return on Equity13,59 %
Debt-to-Equity Ratio−65,42
Operating Profit Margin32,27 %
Current Ratio1,31
Quick Ratio1,31
Equity Ratio−0,02
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English